Dr Metha Apiwattanakul Senior Consultant Neurologist Neurological Institute of Thailand     Dr Hiew Fu Liong Consultant Neurologist Sunway Medical Centre, Malaysia     In...

Multiple sclerosis (MS) is characterised by neuroinflammation, demyelination and neurodegeneration occurring from the earliest phases of the disease; the impact of these pathophysiological processes...

Multiple sclerosis (MS) is an autoimmune, demyelinating and neurodegenerative disease of the central nervous system (CNS) leading to increasing disability over time and reduced health-related quality...

Spinal muscular atrophy (SMA) is a rare hereditary neuromuscular disease characterised by progressive deterioration in motor neuron function leading to increasing skeletal muscle weakness and...

Developmental and epileptic encephalopathies (DEEs) represent a group of epileptic disorders that often appear early in life, and are generally characterized by pharmacoresistant seizures,...

Relapsing multiple sclerosis (MS) is characterised by episodes of inflammatory demyelination in the central nervous system (CNS). While there is limited capacity for the CNS to remyelinate after each...

Janssen-Sponsored Satellite Symposium at the 37th ECTRIMS 2021 Optimising the treatment of people with multiple sclerosis (MS) using prognostic profiling; the  effects of COVID-19 vaccination on...

Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder that can cause non-invasive hamartomatous lesions of any number and size in almost every organ, but are most commonly...

Increasing awareness of Niemann-Pick type C (NP-C) was the focus of the Actelion-sponsored satellite symposium ‘One diagnosis, three presentations, many lives: a biography of Niemann-Pick type C...

Alzheimer’s disease (AD) is associated with progressive deterioration of cognitive and functional abilities (Fig. 1). To date, there is no cure and no validated disease-modifying treatment....